Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani, a Postdoctoral Researcher under the mentorship of Dr. Ian Lewis and Dr. Maen Husein at the University of Calgary. Utilizing the advanced capabilities of the Alberta Centre for Advanced Diagnostics (ACAD), this research has revealed that Tri-Filler™,...
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™ CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the next level of partnership with AMPAK Inc. and the University of Calgary. The new Agreement will see Tri-Filler™ being tested in plastics at AMPAK Inc. facilities with an eye to commercialization. Further to the announcement of the partnership on September 24th, 2020, AMPAK Inc. has signed a new agreement with Biosenta and the University of Calgary that will g...
Biosenta announces further advances in research and development of Tri-Filler™ TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation. Ongoing development of new methods of production of Tri-Filler™ by Dr. Maen Husein of the Department of Chemical Engineering at the University of Calgary and his team have reduced aggregation and resulted in ...
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd. CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( “Biosenta”) (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. About Biosenta Inc. Biosenta is a Canadian-based company that develops and manufactures a range of safe and envi...
Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to collaborate on the commercialization of Biosenta’s Tri-Filler® Products CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP VENTURES Ltd. (“Voran”) which will lead the way for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. The patented new material science Tri-Filler® products could set the new standard in antimicrobial ...
University of Calgary research on Biosenta filler particles yields very encouraging results for the construction industry in the fight against bacteria CALGARY, Alberta, May 25, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is developing environmentally friendly biocidal particles that are successfully tested against infectious bacteria growing on common surfaces. The particles are developed in collaboration with Dr. Maen Husein’s laboratory, University of Calgary, and tested in Dr. Ian Lewis’s laboratory, University of Calgary. Preliminary results showed...
A director at Biosenta Inc sold 316,000 shares at 0.358CAD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Biosenta Announces Note Financing TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE:ZRO) announces that it will enter into a series of prime plus 5% unsecured promissory notes (the “Notes”) in consideration for cash investments in the aggregate amount of $85,000 (together, the “Investment”). The Investment will provide capital for Biosenta to meet the financial requirements of its day-to-day operations and to continue its strategic business plan to grow the company and to capture the growing trend for safe, consumer, commercial a...
Biosenta Announces Record Revenues CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is for an initial order of 145 drums (30,160 litres) of TRUE disinfectant and continued monthly orders. This marks a milestone for Biosenta of achieving record revenues as it continues to implement its strategic plan to position the company to be a leader in the growing disinfectant market in North America. The agreement with SANITIZATION 360 is a perfect fit ...
U.S. Partner Secures Licensing Rights to 2,400 Retail Stores CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) -- On December 21, 2020 Biosenta’s U.S. licensing partner Kleen Bee Labs, LLC has secured licensing rights in Ralphs and Food 4 Less retailers, which are divisions of Kroger Corp. Kroger Corp is one of the largest retailers in the US with approx. 2,400 stores. Kleen Bee Labs long term goal is to distribute in over 10,000 stores across the United States. Kleen Bee Labs’ previously announced deal will ensure Biosenta's patented formulation will continue to expand and be sold at s...
Biosenta growth milestone CALGARY, Alberta, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This marked the third day of Alberta’s Province wide Covid-19 lockdown. This is in step with Biosenta’s strategic business plan grow the company and to capture the growing trend for safe, consumer, commercial and industrial disinfectant with anti-microbial compounds. This comes on the eve of Biosenta receiving the patent for Canada. This is the first step for Biosenta to become a major player in the disinfectant, personal hygiene and anti-microbial categories ...
Biosenta and University of Calgary Research Group launch anti-microbial, nanoparticle development partnership TORONTO, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the finalization of a four-year research partnership with the University of Calgary. Biosenta has wasted no time in creating innovation in Alberta. A research partnership with the University of Calgary Research Group and AMPAK Inc. from Toronto, Ontario, is official. This partnership enables the University team to undertake a new generation ...
Biosenta Announces launching true™ in North America TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE:ZRO) is pleased to announce - Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America. Oil & Gas might come to mind when you think of Calgary, Alberta, but the winds of change are blowing. Am Gill, CEO of Biosenta, has strategically been diversifying the Biosenta team, opening an office in Calgary and recruiting a dynamic team to help scale the organi...
Biosenta Announces its First Sale of Product “True” in Canada TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CNSX (CNSX:ZRO) is pleased to announce it is launching its disinfectant product called “True” in Canada. Originally our product was filed with the trademark “Erase” but we received approval for a name change to “TRUE” to be consistent with the name of Biosenta’s disinfectant previously launched in the US. Am Gill, President and CEO of Biosenta Inc said “We have successfully tested our chemical specifications and are ready to la...
Biosenta Announces its First Sale of Product “True” in the U.S. TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc., (“Biosenta” or the “Company”) listed on the CNSX (CNSX:ZRO), is pleased to announce its first purchase order for its disinfectant product called “True” in the United States. Am Gill, President and CEO of Biosenta Inc said, “This is a milestone announcement for our company. Backed by scientific research and EPA approvals, TRUE is a powerful and safe product that kills many different Viruses, Bacteria, and Fungi. TRUE is different, and better in that it is stable, and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.